BCPC vs AVNT

For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.

8% revenue growth year-over-year, versus 0. 6% for Avient Corporation (AVNT). Balchem Corporation (BCPC) offers the better valuation at 34. 0x trailing P/E (31. 2x forward), making it the more compelling value choice. Analysts rate Balchem Corporation (BCPC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Balchem Corporation (BCPC) is the cheapest at 34.

0x versus Avient Corporation at 42. 5x. On forward P/E, Avient Corporation is actually cheaper at 12. 4x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.

4%, compared to -19. 6% for Avient Corporation (AVNT). Over 10 years, the gap is even starker: BCPC returned +162. 8% versus AVNT's +28. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.

33β versus Avient Corporation's 1. 19β — meaning AVNT is approximately 262% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Balchem Corporation (BCPC) carries a lower debt/equity ratio of 15% versus 81% for Avient Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.

8% versus 0. 6% for Avient Corporation (AVNT). On earnings-per-share growth, the picture is similar: Balchem Corporation grew EPS 20. 9% year-over-year, compared to -51. 6% for Avient Corporation. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Balchem Corporation (BCPC) is the more profitable company, earning 14.

9% net margin versus 2. 5% for Avient Corporation — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus 6. 2% for AVNT. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Avient Corporation (AVNT) trades at 12.

4x forward P/E versus 31. 2x for Balchem Corporation — 18. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 27. 9% to $48. 40.

All stocks in this comparison pay dividends.

Avient Corporation (AVNT) offers the highest yield at 2. 8%, versus 0. 5% for Balchem Corporation (BCPC).

For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

33), 0. 5% yield, +162. 8% 10Y return). Both have compounded well over 10 years (BCPC: +162. 8%, AVNT: +28. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.